Wellington Management Group LLP Has $733 Million Stock Position in Molina Healthcare, Inc $MOH

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Wellington Management Group LLP trimmed its holdings in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 15.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,225,327 shares of the company's stock after selling 406,905 shares during the period. Wellington Management Group LLP owned approximately 4.11% of Molina Healthcare worth $733,000,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently bought and sold shares of the company. Amalgamated Bank increased its position in Molina Healthcare by 0.3% in the 1st quarter. Amalgamated Bank now owns 11,580 shares of the company's stock worth $3,814,000 after purchasing an additional 33 shares during the last quarter. Deseret Mutual Benefit Administrators boosted its stake in shares of Molina Healthcare by 60.7% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after acquiring an additional 34 shares in the last quarter. JLB & Associates Inc. boosted its stake in shares of Molina Healthcare by 0.3% during the 1st quarter. JLB & Associates Inc. now owns 10,626 shares of the company's stock worth $3,500,000 after acquiring an additional 36 shares in the last quarter. Coldstream Capital Management Inc. boosted its stake in shares of Molina Healthcare by 2.1% during the 4th quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock worth $683,000 after acquiring an additional 48 shares in the last quarter. Finally, Rothschild Investment LLC boosted its stake in shares of Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after acquiring an additional 48 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, COO James Woys acquired 10,000 shares of Molina Healthcare stock in a transaction on Monday, August 4th. The stock was bought at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the transaction, the chief operating officer owned 74,331 shares of the company's stock, valued at $11,591,176.14. The trade was a 15.54% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the sale, the director owned 17,131 shares of the company's stock, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is currently owned by company insiders.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $169.48 on Tuesday. The business has a 50 day moving average price of $220.74 and a 200 day moving average price of $280.58. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a twelve month low of $151.95 and a twelve month high of $365.23. The company has a market cap of $9.19 billion, a price-to-earnings ratio of 8.35 and a beta of 0.52.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%. The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. During the same quarter in the prior year, the business posted $5.86 EPS. Molina Healthcare's revenue was up 15.7% compared to the same quarter last year. Research analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on MOH. Sanford C. Bernstein began coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price target for the company. Barclays decreased their price target on Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating for the company in a research note on Friday, July 25th. JPMorgan Chase & Co. decreased their price target on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a research note on Tuesday, July 29th. UBS Group decreased their price target on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Finally, Wall Street Zen downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, Molina Healthcare presently has an average rating of "Hold" and a consensus target price of $242.91.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.